Aurigene Discovery Technologies Limited
Clinical trials sponsored by Aurigene Discovery Technologies Limited, explained in plain language.
-
New pill hopes to fight advanced lymphoma when other treatments fail
Disease control Recruiting nowThis early-phase study tests an experimental oral drug, AUR112, in adults with relapsed advanced lymphoma that has not responded to prior treatments. The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 40 participants will …
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New pill AUR107 enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage study tests an experimental pill called AUR107 in about 50 adults whose advanced cancers have come back after prior treatment. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Participants must be in fairly goo…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New pill aims to tame relapsed lymphomas in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called AUR108 in adults with relapsed advanced lymphomas (cancers of the lymph system). The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 40 participants will take the…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC